STRM.BIO
Develops non-viral gene delivery platform for in vivo cell engineering and gene therapy
$8MSeed2
Role not disclosedR
Recordati
Activity from announced rounds
Activity in this selectioncobalt-capital-0494ba29
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $8M 1 disclosed · full round size, not this investor’s share